FMR1 and fragile X syndrome: Critically, the difference in burst firing can be attributed, unequivocally, to the loss of FMRP expression as the firing properties of both iPSC FXS patient-derived cortical neurons were indistinguishable from those recorded in the FMR1−/y line, a CRISPR-Cas9 gene-edited ESC line.